Cagrilintide modulates appetite through agonistic activity on certain gut hormone receptors, which are pivotal in the neuroendocrine regulation of satiety. By enhancing the physiological response of satiety signals, cagrilintide facilitates a reduction in caloric intake and promotes an early sensation of fullness, aiding in hypophagic behavior.

Weight Reduction

Clinically, cagrilintide has shown promise in contributing to significant weight loss in obese subjects. It potentially does this by not only reducing caloric intake but also by modulating energy homeostasis, thereby promoting adiposity reduction.

Metabolic Parameter Improvement

Cagrilintide may positively impact various metabolic parameters, including glycemic control, lipid profiles, and insulin sensitivity. These effects are crucial for the management of metabolic syndrome components and can decrease the risk of developing type 2 diabetes mellitus and cardiovascular diseases in obese patients.